Keepgoing Sting Relief Pad Cloth
FDA Label NDC 82942-1005

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by J&a Digital Inc. for the product Keepgoing Sting Relief Pad (NDC 82942-1005). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, active ingredient                       purpose, uses:, warnings, keep out of reach of children., directions, inactive ingredients:, product label, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Other

DRUG FACTS

Active Ingredient                       Purpose

Benzocaine 6%..........................Topical Anesthetic

Isopropyl Alcohol 60%................Antiseptic

Uses:

For the temporary relief of pain and itching associated with insect bites, minor burns, sunburn, and minor skin irritations.

Warnings

For external use only. Flammable. Keep away from heat or flame.

  • Avoid contact with the eyes.
  • Stop use and ask a doctor if the condition persists or gets worse.
  • Allergy alert: Do not use this product if you have a history of allergy to local anesthetics such as procaine, butacaine, benzocaine, or other 'caine' anesthetics.
  • Do not use longer than 1 week unless directed by a doctor.

Keep Out Of Reach Of Children.

If swallowed get medical help or contact a Posion Control Center immediately.

Directions

  • Adults and children 2 years of age and older: apply to the affected area not more than 3 to 4 times daily.
  • Do not use in children under 2 years of age.
  • Discard after use.

Inactive Ingredients:

Purified Water.

Product Label

Image Description (Updated Image1 1005)

Image Description (Updated Image1 1005)

Image Description (Updated Image2 1005)

Image Description (Updated Image2 1005)

* Please review the disclaimer below.